Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Leukemia infiltrating the central nervous system structures.
Biomarker and diagnostic research for central nervous system leukemia has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, biologic therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
161 publications have been identified in PubMed for central nervous system leukemia. Research spans Basic Science / Preclinical (22%), Review / Meta-Analysis (20%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 36 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:31 AM UTC
22%
Research summaries | 33 | 20% |
Clinical study results | 28 | 17% |
Disease patterns and progression | 26 | 16% |
Testing and diagnosis research | 17 | 11% |
Patient case studies | 14 | 9% |
New treatment approaches | 7 | 4% |
Jimenez-Mira C (2026). [PMID: 42237881](https://pubmed.ncbi.nlm.nih.gov/42237881/). *Br J Haematol*. [Clinical Trial Publication]
Duguid A (2026). [PMID: 42139054](https://pubmed.ncbi.nlm.nih.gov/42139054/). *Cell Rep*. [Basic Science / Preclinical]
Wong AYL (2026). [PMID: 42185479](https://pubmed.ncbi.nlm.nih.gov/42185479/). *Nat Cancer*. [Basic Science / Preclinical]
Toyama K (2026). [PMID: 41605696](https://pubmed.ncbi.nlm.nih.gov/41605696/). *J Clin Exp Hematop*. [Case Report / Case Series]
Schmidt-Hieber M (2026). [PMID: 42129311](https://pubmed.ncbi.nlm.nih.gov/42129311/). *Bone Marrow Transplant*. [Review / Meta-Analysis]
Ahmed A (2026). [PMID: 42152197](https://pubmed.ncbi.nlm.nih.gov/42152197/). *J Coll Physicians Surg Pak*. [Epidemiology / Natural History]
Denk A (2026). [PMID: 41482158](https://pubmed.ncbi.nlm.nih.gov/41482158/). *Transplant Cell Ther*. [Diagnostic / Biomarker]
Yang S (2026). [PMID: 42046337](https://pubmed.ncbi.nlm.nih.gov/42046337/). *MAbs*. [Gene Therapy / Novel Therapeutics]
Dalla Costa G (2026). [PMID: 40834041](https://pubmed.ncbi.nlm.nih.gov/40834041/). *Expert Opin Drug Saf*. [Review / Meta-Analysis]
Yamamoto J (2026). [PMID: 41962515](https://pubmed.ncbi.nlm.nih.gov/41962515/). *Leuk Res*. [Diagnostic / Biomarker]